Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer

Kerri M. Winters-Stone
Nathan Dieckmann
Gianni F. Maddalozzo
Jill A. Bennett
Christopher W. Ryan
Tomasz M. Beer
ONF 2015, 42(4), 348-356 DOI: 10.1188/15.ONF.348-356

Purpose/Objectives: To determine whether exercise could reduce biomarkers of cancer progression in prostate cancer survivors (PCSs) on androgen-deprivation therapy (ADT).

Design: Randomized, controlled trial.

Setting: Oregon Health and Science University School of Nursing.

Sample: 51 PCSs randomized to one year of resistance and impact training or a stretching control group.

Methods: The authors investigated changes in body composition and cancer-related biomarkers, and the influence of age and fat loss on changes in biomarkers.

Main Research Variables: Body composition (total fat, trunk fat, and lean mass), insulin, insulin-like growth factor-1, and sex hormone–binding globulin.

Findings: In the 36 PCSs with baseline and 12-month data, total fat (p = 0.02) and trunk fat (p = 0.06) mass decreased in the training group compared to gains in controls. Loss of total and trunk fat each mediated the relationship between groups and one-year change in insulin (p < 0.05). Age moderated the insulin response to exercise where insulin reductions were smaller with increasing age (p = 0.03).

Conclusions: Resistance and impact exercise may reduce body fat among PCSs undergoing ADT, in turn exerting an insulin-lowering effect.

Implications for Nursing: Nurses should counsel PCSs to exercise to reduce the risk of obesity and associated conditions, including cancer progression.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or